Cargando…
Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment
The purpose of the study was to compare curability expectations between clinicians and patients and examine the influence of sociodemographic and clinical variables on these expectations and satisfaction within the clinician-patient relationship. This prospective study, conducted from February 2020...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419268/ https://www.ncbi.nlm.nih.gov/pubmed/37570462 http://dx.doi.org/10.3390/healthcare11152222 |
_version_ | 1785088476966813696 |
---|---|
author | Lee, Eun Mi Jiménez-Fonseca, Paula Carmona-Bayonas, Alberto Hernández, Raquel Cruz-Castellanos, Patricia Obispo, Berta Antoñanzas-Basa, Mónica Palacín-Lois, María Castillo-Trujillo, Oscar A. Calderon, Caterina |
author_facet | Lee, Eun Mi Jiménez-Fonseca, Paula Carmona-Bayonas, Alberto Hernández, Raquel Cruz-Castellanos, Patricia Obispo, Berta Antoñanzas-Basa, Mónica Palacín-Lois, María Castillo-Trujillo, Oscar A. Calderon, Caterina |
author_sort | Lee, Eun Mi |
collection | PubMed |
description | The purpose of the study was to compare curability expectations between clinicians and patients and examine the influence of sociodemographic and clinical variables on these expectations and satisfaction within the clinician-patient relationship. This prospective study, conducted from February 2020 to May 2023, involved 986 advanced cancer patients. The patients completed questionnaires assessing treatment efficacy and toxicity predictions and the Scale to Assess the Therapeutic Relationship (STAR). Seventy-four percent of advanced cancer patients had an inaccurate perception of treatment curability. Clinicians perceived male patients with lung or digestive cancer without adenocarcinoma at locally advanced stages, with fewer comorbidities and better functional status (ECOG), as having higher curability expectations. Clinicians tended to have more realistic expectations than patients, since they had to consider the presence of treatment’s side effects, while patients underestimated the possibility of experiencing these adverse effects. Patients who had more favorable expectations regarding survival and quality of life were found to be more satisfied with the care provided by their oncologists. It is crucial for patients to understand the treatment goals and establish realistic expectations in order to actively participate in decision-making and achieve a better quality of life at the end of life. |
format | Online Article Text |
id | pubmed-10419268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104192682023-08-12 Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment Lee, Eun Mi Jiménez-Fonseca, Paula Carmona-Bayonas, Alberto Hernández, Raquel Cruz-Castellanos, Patricia Obispo, Berta Antoñanzas-Basa, Mónica Palacín-Lois, María Castillo-Trujillo, Oscar A. Calderon, Caterina Healthcare (Basel) Article The purpose of the study was to compare curability expectations between clinicians and patients and examine the influence of sociodemographic and clinical variables on these expectations and satisfaction within the clinician-patient relationship. This prospective study, conducted from February 2020 to May 2023, involved 986 advanced cancer patients. The patients completed questionnaires assessing treatment efficacy and toxicity predictions and the Scale to Assess the Therapeutic Relationship (STAR). Seventy-four percent of advanced cancer patients had an inaccurate perception of treatment curability. Clinicians perceived male patients with lung or digestive cancer without adenocarcinoma at locally advanced stages, with fewer comorbidities and better functional status (ECOG), as having higher curability expectations. Clinicians tended to have more realistic expectations than patients, since they had to consider the presence of treatment’s side effects, while patients underestimated the possibility of experiencing these adverse effects. Patients who had more favorable expectations regarding survival and quality of life were found to be more satisfied with the care provided by their oncologists. It is crucial for patients to understand the treatment goals and establish realistic expectations in order to actively participate in decision-making and achieve a better quality of life at the end of life. MDPI 2023-08-07 /pmc/articles/PMC10419268/ /pubmed/37570462 http://dx.doi.org/10.3390/healthcare11152222 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lee, Eun Mi Jiménez-Fonseca, Paula Carmona-Bayonas, Alberto Hernández, Raquel Cruz-Castellanos, Patricia Obispo, Berta Antoñanzas-Basa, Mónica Palacín-Lois, María Castillo-Trujillo, Oscar A. Calderon, Caterina Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment |
title | Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment |
title_full | Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment |
title_fullStr | Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment |
title_full_unstemmed | Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment |
title_short | Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment |
title_sort | clinicians’ and advanced cancer patients’ estimates of treatment efficacy and toxicity in oncologic treatment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419268/ https://www.ncbi.nlm.nih.gov/pubmed/37570462 http://dx.doi.org/10.3390/healthcare11152222 |
work_keys_str_mv | AT leeeunmi cliniciansandadvancedcancerpatientsestimatesoftreatmentefficacyandtoxicityinoncologictreatment AT jimenezfonsecapaula cliniciansandadvancedcancerpatientsestimatesoftreatmentefficacyandtoxicityinoncologictreatment AT carmonabayonasalberto cliniciansandadvancedcancerpatientsestimatesoftreatmentefficacyandtoxicityinoncologictreatment AT hernandezraquel cliniciansandadvancedcancerpatientsestimatesoftreatmentefficacyandtoxicityinoncologictreatment AT cruzcastellanospatricia cliniciansandadvancedcancerpatientsestimatesoftreatmentefficacyandtoxicityinoncologictreatment AT obispoberta cliniciansandadvancedcancerpatientsestimatesoftreatmentefficacyandtoxicityinoncologictreatment AT antonanzasbasamonica cliniciansandadvancedcancerpatientsestimatesoftreatmentefficacyandtoxicityinoncologictreatment AT palacinloismaria cliniciansandadvancedcancerpatientsestimatesoftreatmentefficacyandtoxicityinoncologictreatment AT castillotrujillooscara cliniciansandadvancedcancerpatientsestimatesoftreatmentefficacyandtoxicityinoncologictreatment AT calderoncaterina cliniciansandadvancedcancerpatientsestimatesoftreatmentefficacyandtoxicityinoncologictreatment |